Monitoring and Predicting Breast Cancer Neoadjuvant Chemotherapy Response Using DOSI

NCT02725658 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped This study doesn't meet NIH criteria of clinical trial study

Conditions

Breast Tumor

Interventions

DEVICE: DOSI

Sponsor

Beckman Laser Institute and Medical Center

Collaborators

[object Object]
[object Object]